ISTH-SCC Bleeding Assessment Tool

The ISTH‑SCC Bleeding Assessment Tool is a standardized questionnaire that quantifies lifetime bleeding symptoms to help screen for mild inherited bleeding disorders.

Epistaxis
No or trivial0More than 5 per year or more than 10 mins+1
Cutaneous
No or trivial05 or more bruises (bigger than 1 cm) in exposed areas+1Consultation only+2Extensive+3Spontaneous hematoma requiring blood transfusion+4
Bleeding from minor wounds
No or trivial0More than 5 per year or more than 10 mins+1Consultation only+2Surgical hemostasis+3Blood transfusion, replacement therapy, or desmopressin+4
Oral cavity
No or trivial0Present+1Consultation only+2Surgical hemostasis or antifibrinolytic required+3Blood transfusion, replacement therapy, or desmopressin+4
GI bleeding
No or trivial0Present (not associated with ulcer, portal hypertension, hemorrhoids, angiodysplasia)+1Consultation only+2Surgical hemostasis or antifibrinolytic required+3Blood transfusion, replacement therapy, or desmopressin+4
Hematuria
No or trivial0Present (macroscopic)+1Consultation only+2Surgical hemostasis or iron therapy+3Blood transfusion, replacement therapy, or desmopressin+4
Tooth extraction
No or trivial or none done0Reported in 25% or less of all procedures, no intervention+1Reported in more than 25% of all procedures, no intervention+2Resuturing or packing+3Blood transfusion, replacement therapy, or desmopressin+4
Surgery
No, trivial or none done0Reported in 25% or less of all procedures, no intervention+1Reported in 25% or less of all procedures, no intervention+2Surgical hemostasis or antifibrinolytic+3Blood transfusion, replacement therapy, or desmopressin+4
Menorrhagia
No or trivial0Consultation only, changing pads more frequently than every 2 hours, clot and flooding, or PBAC score more than 100+1Time off work or school more than 2 per year, requiring antifibrinolytics, or hormonal or iron therapy+2Requiring combined treatment with antifibrinolytics and hormonal therapy or menorrhagia present since menarche and more than 12 months+3Acute menorrhagia requiring hospital adminssion and emergency treatment, requiring blood transfusion or replacement therapy or desmopressin, requiring dilatation and curettage or endometrial ablation or hysterectomy+4
Postpartum hemorrhage
No, trivial or no deliveries0Consultation only, use of oxytocin, or lochia more than 6 weeks+1Iron therapy or antifibrinolytics+2Requiring blood transfusion, replacement therapy, desmopressin, or requiring examination under anesthesia and or the use of uterine balloon or package to tamponade the uterus+3Any procedure requiring critical care or surgical intervention+4
Muscle hematomas
Never0Post trauma or no therapy+1Spontaneous or no therapy+2Spontaneous or traumatic, requiring desmopressin or replacement therapy+3Spontaneous or traumatic, requiring surgical intervention or blood transfusion+4
Hemarthrosis
Never0Post trauma or no therapy+1Spontaneous or no therapy+2Spontaneous or traumatic, requiring desmopressin or replacement therapy+3Spontaneous or traumatic, requiring surgical intervention or blood transfusion+4
CNS bleeding
Never0Subdural or any intervention+3Intracerebral or any intervention+4
Other bleeding
No or trivial0Post trauma or no therapy+1Spontaneous or no therapy+2Spontaneous or traumatic, requiring desmopressin or replacement therapy+3Spontaneous or traumatic, requiring surgical intervention or blood transfusion+4

Indicazioni d'uso

Used to quantify lifelong bleeding symptoms and identify patients who may need evaluation for VWD or other mild bleeding disorders. Recommended for screening/documenting phenotype, not for ordering labs, per VWD guidelines 1 [Level I evidence]. Helps distinguish significant from trivial mucocutaneous bleeding and guides second‑line testing in suspected mild disorders (BDUC, VWD, IPFD) 2 [Level III evidence]. Not reliable for predicting future bleeding 3 [Level II evidence].

Approfondimenti e precauzioni

Flags bleeding symptoms that suggest an inherited disorder but overestimates risk in anxiety‑prone or anemic patients and underperforms in older adults. Not validated for procedure‑specific bleeding prediction and cannot replace coagulation testing when clinically indicated. Moderate inter‑rater variability limits reliability, and scores are not actionable for perioperative decisions (Circulation review of perioperative tools 1 [Level III evidence]).